Fundraising FoxUI Investissement — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis).
BiotechDeep TechDigital HealthMedical DevicesParis, FR
Harry Sokol(Scientific Co-founder)in
Co-investorsBpifranceAgoranovForepont Capital PartnersAuriga Partners
Gleamer develops AI copilot software for medical imaging that assists radiologists in detecting pathologies and generating diagnostic reports across X-ray, CT, and MRI modalities.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechMedical DevicesParis, FR
Christian Allouche(Founder)inAlexis Ducarouge(Founder)inDr Nor-Eddine Regnard(Founder)
Co-investorsXAngeBpifranceElaiaHeal CapitalKima VenturesSupernova Invest+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.